A Phase III, Comparative Study for the Efficacy and Safety of Bilastine 20 mg Versus Cetirizine 10 mg and Placebo in the Treatment of Perennial Allergic Rhinitis During 4 Weeks, Followed by a Long-term Safety Extension With Bilastine 20 mg.

Trial Profile

A Phase III, Comparative Study for the Efficacy and Safety of Bilastine 20 mg Versus Cetirizine 10 mg and Placebo in the Treatment of Perennial Allergic Rhinitis During 4 Weeks, Followed by a Long-term Safety Extension With Bilastine 20 mg.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Mar 2012

At a glance

  • Drugs Bilastine; Cetirizine
  • Indications Perennial allergic rhinitis
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 20 Mar 2012 Last checked against ClinicalTrials.gov record.
    • 13 Nov 2011 Results published in the Current Medical Research and Opinion.
    • 24 May 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top